Healthcare VC, Barcelona

Asabys Partners

Venture capital firm · Barcelona · Founded July 2020

Quick read

Asabys Partners is a Barcelona-based healthcare VC founded in July 2020. It backs healthtech and biopharma companies across Spain and Europe, with ambitions to build a beyond €1 billion life sciences platform by 2030. The firm runs multiple funds under the Sabadell Asabys Health Innovation Investments brand and recently absorbed Aliath Bioventures to expand its team and reach.

Key facts

Founded
July 2020
Employees
292
Sectors
healthcare, biotech
Website
asabys.com

Investment thesis

Asabys invests across healthtech and biopharma — from digital health to drug discovery — with a focus on Spain and Southern Europe, targeting companies pushing the scientific boundaries of human healthcare.

Recent activity

  • Oct 2025fundraise
    Asabys Partners integrated Aliath Bioventures (formerly Alta Life Sciences) in a strategic consolidation backed by AltamarCAM Partners, lifting AUM from $351 million to over $468 million. The firm set a target of exceeding €1 billion AUM by 2030, with expansion plans covering tech transfer, company creation, scale-ups, and growth-stage deals. Both firms had previously co-invested in Deepull, Ona Therapeutics, and Inbrain Neuroelectronics. bioxconomy.com
  • 2026investment
    Asabys launched Oriva Therapeutics, a pre-seed women's health biotech it created by combining two clinical-stage assets from Oncostellae and Medibiofarma. The Sabadell Asabys II fund led the pre-seed round. Oriva's lead program, ORV-362, a non-hormonal therapy for endometriosis, entered Phase I in January 2026; a second program targeting uterine fibroids is expected in Phase I in Q1 2027. catalonia.health
  • 2026investment
    Asabys led the first closing of Augustine Therapeutics' Series A at €17 million, with co-investors Eli Lilly and the US-based Charcot-Marie-Tooth Research Foundation. The Belgian biotech focuses on treatments for neurodegenerative and cardiometabolic diseases. Clara Campàs joined Augustine's Board of Directors in connection with the round. cbinsights.com
  • 2026investment
    Nuage Therapeutics, a spin-off from IRB Barcelona and ICREA co-founded by researcher Xavier Salvatella, closed a financing round backed by Sabadell Asabys. The company targets drug discovery against therapeutic targets currently considered undruggable. startupsreal.com
  • ~Apr 2026leadership
    Montserrat Vendrell, Partner at Asabys Partners, was elected to the Board of AseBio (Asociación Española de Bioempresas) for a new term. es.linkedin.com
  • ~Apr 2026leadership
    Asabys opened a search for a new Partner focused on early-stage investments, signalling a planned expansion of its investment team. es.linkedin.com
  • Sep 2024fundraise
    Asabys closed its second fund, Sabadell Asabys Health Innovation Investments II (SAHII II), at €180 million total commitments. The fund was oversubscribed. At that point the firm reported close to €300 million in AUM across both funds (Fund I: €117 million, Fund II: €180 million). vcwire.tech
  • Nov 2025investment
    Participated in Qida's €37M Series C round — Spain's digital home care platform for aging. tracxn.com
  • Nov 2025investment
    Co-led investment round in Miramoon Pharma alongside Alta Life Sciences and Columbus Venture Partners. tracxn.com
  • 2025leadership
    Integrated Aliath Bioventures' team and began co-managing Alta Life Sciences Spain I FCR fund with AltamarCAM, advancing its goal to build a €1B+ European life sciences platform by 2030. zoominfo.com
  • 2025investment
    Invested in SpliceBio's $135M Series B round. zoominfo.com
  • 2025investment
    Invested in SafeHeal's $51.5M Series C funding round. zoominfo.com

Notable investments

Key people

Named individuals at the firm. We don't expose direct email or phone — use their LinkedIn for outreach.

  • Sylvain Sachot · Partner
  • Guillem Masferrer · Partner
  • Josep Lluis Sanfeliu · Founder & Managing Partner
  • Clara Campàs · Founding Partner

Sources

Other VCs in Spain

Explore VCs by sector

Globally

Frequently asked

What is Asabys Partners?+

Asabys Partners is a Barcelona-based healthcare VC founded in July 2020. It backs healthtech and biopharma companies across Spain and Europe, with ambitions to build a beyond €1 billion life sciences platform by 2030.

Where is Asabys Partners headquartered?+

Asabys Partners is headquartered in Barcelona, Spain.

When was Asabys Partners founded?+

Asabys Partners was founded in July 2020.

What sectors does Asabys Partners invest in?+

Asabys Partners focuses on healthcare, biotech. They primarily invest in these sectors.

How do I prepare for a meeting with Asabys Partners?+

Brief generates a structured pre-meeting briefing on any person at Asabys Partners — quick read, recent activity, points of view, and conversation openers tailored to what you sell. Sign in to get personalised openers for your product.

Meeting with someone at Asabys Partners?

Brief generates a structured pre-meeting briefing on any person in seconds.

Try Brief →

Generated by briefthecall.com from public web sources. Last updated July 9, 2026. Each claim is linked to its source above.

Automatically generated by AI from public sources. May be inaccurate or out of date. Remove or correct this profile →